Formenti et al. discovered that patients with NSCLC who were previously unresponsive to IO had a positive response after treatment with a combination of RT and CTLA-4 blockade, leading to significantly extended survival time in some cases [23]. Here, CTLA4 is linked to non-small cell lung carcinoma.